BIIB vs. CAH
BIIB (Biogen Inc.) and CAH (Cardinal Health, Inc.) are both stocks. Both are in the Healthcare sector — BIIB in Drug Manufacturers - General, CAH in Medical Distribution. Over the past 10 years, BIIB returned -1.49%/yr vs 14.97%/yr for CAH. At a 0.23 correlation, their price movements are largely independent.
Performance
BIIB vs. CAH - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with BIIB having a 12.05% return and CAH slightly lower at 11.94%. Over the past 10 years, BIIB has underperformed CAH with an annualized return of -1.49%, while CAH has yielded a comparatively higher 14.97% annualized return.
BIIB
- 1D
- -1.26%
- 1M
- 1.77%
- YTD
- 12.05%
- 6M
- 12.80%
- 1Y
- 58.06%
- 3Y*
- -11.50%
- 5Y*
- -10.80%
- 10Y*
- -1.49%
CAH
- 1D
- 2.77%
- 1M
- 14.07%
- YTD
- 11.94%
- 6M
- 10.93%
- 1Y
- 41.16%
- 3Y*
- 37.90%
- 5Y*
- 35.52%
- 10Y*
- 14.97%
BIIB vs. CAH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIIB Biogen Inc. | 12.05% | 15.09% | -40.91% | -6.55% | 15.42% | -2.02% | -17.48% | -1.39% | -5.54% | 12.34% |
CAH Cardinal Health, Inc. | 11.94% | 76.25% | 19.01% | 34.15% | 54.08% | -0.40% | 10.09% | 18.04% | -24.50% | -12.65% |
Correlation
The correlation between BIIB and CAH is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Sep 17, 1991 | 0.23 |
The correlation between BIIB and CAH shifts across timeframes, from 0.04 (1 year) to 0.26 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
BIIB:
$12.48
CAH:
$6.55
BIIB:
15.79
CAH:
34.95
BIIB:
1.09
CAH:
0.83
BIIB:
2.20
CAH:
0.22
BIIB:
$9.86B
CAH:
$250.55B
BIIB:
$5.06B
CAH:
$9.23B
BIIB:
$2.24B
CAH:
$2.79B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIIB vs. CAH — Risk / Return Rank
BIIB
CAH
BIIB vs. CAH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Biogen Inc. (BIIB) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIIB | CAH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.38 | ||
| Sortino ratioReturn per unit of downside risk | +0.33 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.30 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 4.07 | 2.03 | +2.04 |
| Martin ratioReturn relative to average drawdown | 10.16 | 5.32 | +4.84 |
Loading charts...
Drawdowns
BIIB vs. CAH - Drawdown Comparison
The maximum BIIB drawdown since its inception was -89.98%, which is greater than CAH's maximum drawdown of -61.93%. Use the drawdown chart below to compare losses from any high point for BIIB and CAH.
Loading charts...
Drawdown Indicators
| BIIB | CAH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.98% | -61.93% | -28.05% |
Max Drawdown (1Y)Largest decline over 1 year | -14.34% | -20.42% | +6.08% |
Max Drawdown (3Y)Largest decline over 3 years | -60.34% | -20.42% | -39.92% |
Max Drawdown (5Y)Largest decline over 5 years | -69.28% | -22.80% | -46.48% |
Max Drawdown (10Y)Largest decline over 10 years | -72.66% | -46.13% | -26.53% |
Current DrawdownCurrent decline from peak | -58.57% | -0.18% | -58.39% |
Average DrawdownAverage peak-to-trough decline | -36.63% | -15.93% | -20.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.73% | 7.76% | -2.03% |
Volatility
BIIB vs. CAH - Volatility Comparison
Biogen Inc. (BIIB) has a higher volatility of 8.42% compared to Cardinal Health, Inc. (CAH) at 6.99%. This indicates that BIIB's price experiences larger fluctuations and is considered to be riskier than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIIB | CAH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.42% | 6.99% | +1.43% |
Volatility (6M)Calculated over the trailing 6-month period | 24.36% | 20.60% | +3.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.40% | 30.13% | +3.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.27% | 25.26% | +9.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.30% | 29.26% | +12.04% |
Dividends
BIIB vs. CAH - Dividend Comparison
BIIB has not paid dividends to shareholders, while CAH's dividend yield for the trailing twelve months is around 0.89%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIIB Biogen Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CAH Cardinal Health, Inc. | 0.89% | 0.99% | 1.28% | 1.98% | 2.57% | 3.80% | 3.62% | 3.80% | 4.24% | 3.00% | 2.41% | 1.68% |
Financials
BIIB vs. CAH - Financials Comparison
This section allows you to compare key financial metrics between Biogen Inc. and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BIIB vs. CAH - Profitability Comparison
BIIB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Biogen Inc. reported a gross profit of 0.00 and revenue of 2.48B. Therefore, the gross margin over that period was 0.0%.
CAH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported a gross profit of 2.50B and revenue of 60.94B. Therefore, the gross margin over that period was 4.1%.
BIIB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Biogen Inc. reported an operating income of 0.00 and revenue of 2.48B, resulting in an operating margin of 0.0%.
CAH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported an operating income of 509.00M and revenue of 60.94B, resulting in an operating margin of 0.8%.
BIIB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Biogen Inc. reported a net income of 319.50M and revenue of 2.48B, resulting in a net margin of 12.9%.
CAH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported a net income of 399.00M and revenue of 60.94B, resulting in a net margin of 0.7%.
Frequently Asked Questions
BIIB and CAH have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIIB has higher volatility (8.42%) compared to CAH (6.99%). In terms of maximum drawdown, BIIB dropped -89.98% vs CAH's -61.93%.
BIIB currently has the higher Sharpe Ratio (1.75 vs 1.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIIB and CAH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer